End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8.71 CNY | +1.28% | +1.16% | -44.87% |
May. 16 | Olymvax Biopharma's Flu Vaccine Gets China Nod for Clinical Trials | MT |
Apr. 25 | Chengdu Olymvax Biopharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-44.87% | 483M | |
-1.36% | 89.49B | |
+2.24% | 40.67B | |
-12.97% | 33.15B | |
+61.72% | 26.45B | |
-20.71% | 14.69B | |
-7.31% | 12.89B | |
-12.64% | 11.54B | |
-42.60% | 11.34B | |
+4.27% | 8.84B |
- Stock Market
- Equities
- 688319 Stock
- News Chengdu Olymvax Biopharmaceuticals Inc.
- Olymvax Biopharma Gets Nod to Amend Packaging of Adsorbed Tetanus Vaccine